BRCA1 and breast cancer: Despite this limitation, the study size was sufficient to demonstrate that BRCA1-associated tumors are generally more chemosensitive than non-hereditary BCs, irrespective of whether the comparison is performed in the entire patient population or in women with triple-negative BC.